Anthracyclines News and Research

RSS
Advances in treatment have improved the chances of survival for young patients with cancer

Advances in treatment have improved the chances of survival for young patients with cancer

Michigan's first cardio-oncology clinic launched to prevent heart problems

Michigan's first cardio-oncology clinic launched to prevent heart problems

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

ImmunoGen to present IMGN901 clinical data on multiple myeloma at 54th ASH annual meeting

ImmunoGen to present IMGN901 clinical data on multiple myeloma at 54th ASH annual meeting

No advantage of continuous over bolus doxorubicin in ALL children

No advantage of continuous over bolus doxorubicin in ALL children

Cell Therapeutics launches Pixuvri in the European Union

Cell Therapeutics launches Pixuvri in the European Union

Chemotherapy during pregnancy: an interview with Professor Sibylle Loibl

Chemotherapy during pregnancy: an interview with Professor Sibylle Loibl

Study examines whether eribulin offers added benefit to women with breast cancer

Study examines whether eribulin offers added benefit to women with breast cancer

Breast cancer drug bevacizumab slows progression but has no overall survival benefit

Breast cancer drug bevacizumab slows progression but has no overall survival benefit

CytRx INNO-206 doxorubicin conjugate shows anti-multiple myeloma effects

CytRx INNO-206 doxorubicin conjugate shows anti-multiple myeloma effects

New light on many biological differences between individual breast cancers

New light on many biological differences between individual breast cancers

Potential breast cancer patients for new immune-targeting therapies

Potential breast cancer patients for new immune-targeting therapies

EAE, ASE to issue echocardiography guidelines for early detection of cardio toxicity

EAE, ASE to issue echocardiography guidelines for early detection of cardio toxicity

Niiki Pharma announces positive data from ongoing trial of novel anti-cancer agent NKP-1339

Niiki Pharma announces positive data from ongoing trial of novel anti-cancer agent NKP-1339

Trastuzumab drug increases risk of heart problems in elderly breast cancer patients

Trastuzumab drug increases risk of heart problems in elderly breast cancer patients

ImmunoGen's IMGN901 Phase I trial data on multiple myeloma presented at ASCO 2011

ImmunoGen's IMGN901 Phase I trial data on multiple myeloma presented at ASCO 2011

Nektar reports positive results from NKTR-102 Phase 2 study in metastatic breast cancer at CTRC-AACR SABCS

Nektar reports positive results from NKTR-102 Phase 2 study in metastatic breast cancer at CTRC-AACR SABCS

Multi-disciplinary approach increases breast cancer survival rate: Study

Multi-disciplinary approach increases breast cancer survival rate: Study

Impact of cancer treatment on cardiovascular function

Impact of cancer treatment on cardiovascular function

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia